Views & Reviews From the Frontline

Bad medicine: type 2 diabetes

BMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1216 (Published 03 March 2010) Cite this as: BMJ 2010;340:c1216
  1. Des Spence, general practitioner, Glasgow
  1. destwo{at}yahoo.co.uk

    Type 2 diabetes is yet another “ticking time bomb.” With a tripling in the rate to 6% of UK men, and with general practitioners berated for the undiagnosed “missing million” cases, the number of people with diabetes is predicted to double in 20 years. The rationale for detection and treatment, supported by large observational studies, is to prevent cardiovascular and microvascular disease. This research also promotes aggressive control of glycated haemoglobin A1C, blood pressure, and cholesterol—a mantra of “the lower the better.” So people with diabetes are potentially prescribed three drugs to control …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe